Export 168 results:
Author Title Type [ Year
] Filters: First Letter Of Last Name is M [Clear All Filters]
.
2025. Identifying bellwether sewershed sites for sustainable disease surveillance in Bengaluru, India: a longitudinal study [Next Gen Genomics Facility (INT)]. The Lancet Regional Health - Southeast Asia. 39:100619.
.
2025. Identifying bellwether sewershed sites for sustainable disease surveillance in Bengaluru, India: a longitudinal study [Next Gen Genomics Facility (INT)]. The Lancet Regional Health - Southeast Asia. 39:100619.
.
2025. Identifying bellwether sewershed sites for sustainable disease surveillance in Bengaluru, India: a longitudinal study [Next Gen Genomics Facility (INT)]. The Lancet Regional Health - Southeast Asia. 39:100619.
.
2025. Identifying bellwether sewershed sites for sustainable disease surveillance in Bengaluru, India: a longitudinal study [Next Gen Genomics Facility (INT)]. The Lancet Regional Health - Southeast Asia. 39:100619.
.
2024. Macrophage-conditioned medium enhances tunneling nanotube formation in breast cancer cells via PKC, Src, NF-κB, and p38 MAPK signaling [Next Gen Genomics Facility]. Cell Signal. :111274.
.
2024. Multiplexed fluorescence and scatter detection with single cell resolution using on-chip fiber optics for droplet microfluidic applications [Discovery to Innovation Accelerator, C-CAMP]. Microsyst Nanoeng. 10:35.
.
2024. Multiplexed fluorescence and scatter detection with single cell resolution using on-chip fiber optics for droplet microfluidic applications [Discovery to Innovation Accelerator, C-CAMP]. Microsyst Nanoeng. 10:35.
.
2024. Role of Mating Receptivity Peptides in Helicoverpa armigera: Molecular and Evolutionary Perspectives [Mass Spectrometry - Proteomics Facility]. Journal of Advances in Biology & Biotechnology. 27 (8)
.
2023. Comparative stability study and aggregate analysis of Bevacizumab marketed formulations using advanced analytical techniques [Biologics / Biopharmaceutical Characterization Facility]. Heliyon. 9:e19478.
.
2023. Comparative stability study and aggregate analysis of Bevacizumab marketed formulations using advanced analytical techniques [Biologics / Biopharmaceutical Characterization Facility]. Heliyon. 9:e19478.
.
2023. CRISPR/Cas9 and FLP-FRT mediated regulatory dissection of the BX-C of Drosophila melanogaster [Transgenic Fly Facility]. Chromosome Res. 31(1):7.
.
2023. Distinct evolution of type I glutamine synthetase in Plasmodium and its species-specific requirement [Mass Spectrometry Facility - Metabolomics]. Nat Commun. 14(1):4216.
.
2023. Identification of key amino acid residues in OqxB mediated efflux of fluoroquinolones using site-directed mutagenesis [Bugworks Research Pvt. Ltd., a C-CAMP Startup]. Res Microbiol. :104039.
.
2023. A new species of Bufoides Pillai and Yazdani 1973 (Amphibia: Bufonidae) from Mizoram (India) and the delimitation of the distribution range of Bufoides meghalayanus (Yazdani & Chanda 1971) to the Khasi hills, Meghalaya (India) [Next Gen Genomics Facility]. Biodiversitas Journal of Biological Diversity. Vol. 24 No. 9(No. 9)
.
2022. Dual control of dopamine in Drosophila myeloid-like progenitor cell proliferation and regulation of lymph gland growth. [Central Imaging & Flow Cytometry Facility]. EMBO Rep. :e52951.
.
2022. Dual control of dopamine in Drosophila myeloid-like progenitor cell proliferation and regulation of lymph gland growth. [Central Imaging & Flow Cytometry Facility]. EMBO Rep. :e52951.
.
2022. Effect of Altitude on Volatile Organic and Phenolic Compounds of Artemisia brevifolia Wall ex Dc. From the Western Himalayas [Mass Spectrometry Facility]. Frontiers in Ecology and Evolution. 10
.
2022. Effectiveness of a novel, non-intrusive, continuous-use air decontamination technology to reduce microbial contamination in clinical settings: a multi-centric study [Biomoneta Research Pvt. Ltd., a C-CAMP Startup]. J Hosp Infect. 123:15-22.
.
2022. Effectiveness of a novel, non-intrusive, continuous-use air decontamination technology to reduce microbial contamination in clinical settings: a multi-centric study [Biomoneta Research Pvt. Ltd., a C-CAMP Startup]. J Hosp Infect. 123:15-22.
.
2022. Immune profile and responses of a novel dengue DNA vaccine encoding an EDIII-NS1 consensus design based on Indo-African sequences [C-CAMP Bioincubation Facility]. Molecular Therapy - Cell Press.
.
2022. Immune profile and responses of a novel dengue DNA vaccine encoding an EDIII-NS1 consensus design based on Indo-African sequences [C-CAMP Bioincubation Facility]. Molecular Therapy - Cell Press.
.
2022. Immune profile and responses of a novel dengue DNA vaccine encoding an EDIII-NS1 consensus design based on Indo-African sequences [C-CAMP Bioincubation Facility]. Molecular Therapy - Cell Press.
.
2022. Immune profile and responses of a novel dengue DNA vaccine encoding an EDIII-NS1 consensus design based on Indo-African sequences [C-CAMP Bioincubation Facility]. Molecular Therapy - Cell Press.